Technology Oramed Granted Key European Patent for Platform Technology in Oral Delivery of ProteinsBy adminJanuary 5, 20220 New YorkAnd January 5 2022 /PRNewswire/ — Oramed Pharmaceuticals Inc. (Nasdaq/TASE: ORMP) (www.oramed.com), a clinical-phase pharmaceutical company focused on developing oral drug delivery platforms, today announced… Read More
